{"title":"《柳叶刀传染病2024》修正；24: 1045 - 58","authors":"","doi":"10.1016/s1473-3099(24)00859-4","DOIUrl":null,"url":null,"abstract":"<em>Bézay N, Wagner L, Kadlecek V, et al. Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies.</em> Lancet Infect Dis <em>2024;</em> 24: <em>1045–58</em>—The appendix of this Article has been updated as of Dec 19, 2024.","PeriodicalId":49923,"journal":{"name":"Lancet Infectious Diseases","volume":"19 1","pages":""},"PeriodicalIF":29.4000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to Lancet Infect Dis 2024; 24: 1045–58\",\"authors\":\"\",\"doi\":\"10.1016/s1473-3099(24)00859-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<em>Bézay N, Wagner L, Kadlecek V, et al. Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies.</em> Lancet Infect Dis <em>2024;</em> 24: <em>1045–58</em>—The appendix of this Article has been updated as of Dec 19, 2024.\",\"PeriodicalId\":49923,\"journal\":{\"name\":\"Lancet Infectious Diseases\",\"volume\":\"19 1\",\"pages\":\"\"},\"PeriodicalIF\":29.4000,\"publicationDate\":\"2024-12-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/s1473-3099(24)00859-4\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s1473-3099(24)00859-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
bassazay N, Wagner L, Kadlecek V，等。在健康成人中优化VLA15莱姆氏螺旋体病候选疫苗的剂量水平和接种计划：两项随机、观察者盲、安慰剂对照、多中心、2期研究柳叶刀感染病2024；[04:1045 - 58]本文的附录已于2024年12月19日更新。
Bézay N, Wagner L, Kadlecek V, et al. Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies. Lancet Infect Dis 2024; 24: 1045–58—The appendix of this Article has been updated as of Dec 19, 2024.
期刊介绍：
The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.The infectious diseases journal aims to be a world-leading publication, featuring original research that advocates change or sheds light on clinical practices related to infectious diseases. The journal prioritizes articles with the potential to impact clinical practice or influence perspectives. Content covers a wide range of topics, including anti-infective therapy and immunization, bacterial, viral, fungal, and parasitic infections, emerging infectious diseases, HIV/AIDS, malaria, tuberculosis, mycobacterial infections, infection control, infectious diseases epidemiology, neglected tropical diseases, and travel medicine. Informative reviews on any subject linked to infectious diseases and human health are also welcomed.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
